Glaucoma is the name given to a group of eye diseases that causes damage to the optic nerve fibers and can lead to progressive vision loss or blindness if left untreated. The damage is primarily a result of the buildup of intraocular pressure, which results when an imbalance occurs in the production and drainage of aqueous humour. However, some glaucoma is not distinguished by high intraocular pressure, but as optic nerve damage. In the human eye the ciliary body constantly creates aqueous humour to provide sustenance for surrounding tissues. To maintain a healthy balance as new fluid is produced, older fluid must leave the eye through the meshwork drainage system along the periphery of the iris. If too much aqueous humour is produced or the drainage system is not working properly, consequently intraocular pressure builds, causing optic nerve fiber damage and deterioration of vision.
The main treatment for glaucoma is topical eye drops, but in cases where a patient is on maximum eye drops and intraocular pressure is not controlled, or the side effects are too extensive or the age and ability of
…show more content…
In general, laser treatment involves creating either a very small burn or opening in the eye tissue (depending on the strength of the beam) to drain the aqueous humour and release the intraocular pressure. Initially, freezing drops are put into the eye and chin and forehead are placed onto a special microscope called a slit lamp. A special lens is that helps prevent blinking and guides the highly fixed beam of light is then placed in front of the eye. This is then followed by one of several possible laser treatments, chosen depending on the type of glaucoma present: Laser Trabeculoplasty – Selective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT); Laser Peripheral Iridotomy (LPI); and Diode Laser
Signs/Symptoms: The way a person would know if they have Glaucoma, an eye disease that can make someone go blind, is by looking for the signs or symptoms. Symptoms of Open Angle Glaucoma are patchy blindness spots in the peripheral or central vision and “tunnel” vision in both eyes. The symptoms for Acute Angle-Closure Glaucoma are, as said by Glaucoma - Symptoms and Causes by The Mayo Clinic “eye pain, nausea and vomiting, blurred vision, “halos” around lights - which may be rainbow,” red eyes, and sudden sight loss. The symptoms of this kind of Glaucoma have no typical early warning signs. This is the reason people don’t notice it until it is too late, and they end up losing their vision if it is not treated.
The guidelines of the European Glaucoma Society (EGS) for the management of glaucoma due to corticosteroid treatment are; (1) discontinuation of corticosteroid therapy or switch to weaker steroid (2) administration of topical or systemic IOP lowering medications (3) laser trabeculoplasty and (4) glaucoma surgery in intractable cases. These recommendations are, however, not specific for intravitreal administration of
There are several types of glaucoma. The two main types of glaucoma, are open-angle glaucoma and angle-closure glaucoma. In open-angle glaucoma, the angle the angle in your eye where the iris meets, the cornea is as wide and open as it should be, but the eye’s drainage canals become clogged over time, causing an increase in internal eye pressure and later damaging the optic nerve. Angle-closure glaucoma is caused by a rapid or sudden increase in intraocular pressure (IOP), the pressure in the eye. A fluid is continually produced inside, and drains out of, the normal eye. The fluid, is called aqueous humor. Aqueous humor is not like tears, which are only on the outside of the eye.
"Glaucoma is a condition that causes damage to your eye's optic nerve and gets worse over time". (WebMD) Glaucoma is interlinked with the pressure in the eye. No one knows the exact cause of the glaucoma. Doctors think the main cause of the glaucoma is the pressure in the eye. Some people with the normal eye pressure also suffer with glaucoma. There are different kinds of glaucoma such as open angle glaucoma, Angle closure glaucoma, Normal tension glaucoma, Congenital and infantile glaucoma, and secondary glaucoma’s. Beta–adrenergic blockers and prostaglandins are the most frequently used topical medications at present.
When comparing the chemical ablation, TSCP, evisceration and the drainage shunts, all are considered good treatment options for glaucoma because they can maintain a low intraocular pressure long term. The chemical ablation and TSCP worked well for some patients, but some needed a second treatment for it to be successful. While the drainage shunt shows promise, data suggests that it is not as good as the other treatments due to the high risk of fibrin obstructing the shunt. That makes it a good short term glaucoma treatment, but it would eventually need to be removed and a second procedure would need to follow
This case study follows a 63-year-old Caucasian man with a 55-year history of long-standing retinal detachment after trauma. He came into their facility and presented pain and redness, a total hyphema, no light perception vision and an intraocular pressure of 60 mmHg (right eye). He disclosed that he has a history of diabetes and coronary artery disease. He also stated he was hit in the eye with a stone 55 years ago. Following anterior chamber washout, he was found to have neovascular glaucoma. After washout and intraocular pressure control, his visual acuity improved to light perception. He underwent vitrectomy, membrane peeling, endolaser and silicone oil placement to reattach his retina, and then a second retinal reattachment procedure Following
Glaucoma is a "multi-factorial, complex eye disease with specific characteristics such as optic nerve damage and visual field loss". It embodies many conditions, all of which can harm or damage the optic nerve and the retina, which can solemn lead to blindness if left untreated. Generally, glaucoma is connected to and is associated with high IOP. IOP fluctuates throughout the day, so it can be both high and low and different periods of time. IOP can occur when the drainage channels within the eye become slightly or fully blocked, therefore preventing the fluid located within the eyeball (aqueous humour) from draining or excreting properly and resulting in a build-up of pressure. Once damage or loss of vision has occurred, it cannot be reversed, but treatment can help prevent further harm to the eyes. Often, treatments start with giving eye drops, which can work toward reducing IOP by either reducing the production of aqueous humour or by assisting fluids out of the eyes. Traditionally speaking, the screening which were done for glaucoma happened at an optician’s check-up. Now however, there are tests which measure the IOP, by using snapshot reading. With this method, even borderline cases can be missed. Thankfully, a new, smart electronic contact lens called the Triggerfish Sensor is currently being used for the first time in fight against a leading cause of blindness. This sensor could assist experts diagnose the eye problem earlier and treat it more efficiently and effectively. The Triggerfish lens is made up of soft silicone and is a single use item piece. The sensor on the lens contains a microprocessor, an adhesive receiving antenna and a small battery-operated recorder. The antenna is strapped/fixed to the side of the head and around the eyes and continuously receives data input or wireless readings from the chip in the lens. After the 24-hour period that the lens is on
It's usually resolved through surgery which can restore a large percentage of vision unlike with glaucoma.
A 6-year-old male underwent an initial eye examination for evaluation of hyperpigmentation of both eyes at 1 year of age. He was diagnosed with benign conjunctival melanosis. He was also diagnosed with an increased cup-to-disc ratio and mildly elevated intraocular pressures in each eye. Intraocular pressure was maintained in the mid-teens bilaterally on topical glaucoma monotherapy. At 4 years of age, he relocated. When he was 5-years-old, he underwent bilateral glaucoma shunt placement elsewhere The operative reports and glaucoma drainage implant (GDI) specifics were not obtainable. No prior or subsequent ocular surgeries were performed. He returned to our care after 2 years. His eye pressures were controlled without glaucoma medications. There were GDIs in the superotemporal quadrant of each eye. In the right eye, there was corneal edema in the superotemporal quadrant extending to the pupillary margin and a 3 millimeter central subcapsular cataract. The shunt tube extended into the anterior chamber approximately 2 millimeters (Figure 1A). The anterior portion of the tube retracted posterior and was barely visible in the anterior chamber with adduction of the eye (Figure 1B). Upon abduction, the tip of the tube travelled up to 6 mm towards the 4:00 position (Figure 2A) (Video). Intermittently, the tip of the tube would dive posterior to the iris at the 4:00 position to touch the lens (Figure 2B).
Glaucoma develops when a fluid called aqueous humour within the eyes cannot drain properly and pressure builds up, known as the intraocular pressure. Under normal circumstances, the fluid would be drained out of the eyes through tubes. This can damage the optic nerve and also the nerve fibres from the Retina. The Retina is the layer of light-sensitive tissue that lines the back of the eye.
painful and stressful disorder that can cause unrepairable sight problems, if left un-treated. How do we treat this disease? As the research shows there has not been a dramatic change in the eye drop treatment approach, to manage this disease. Dry eye is a common condition and often a chronic problem (particularly in older adults), in which a person does not have enough quality tears to lubricate and nourish the eye. Dry eye disease is a multifactorial disease in the ocular
The pathogenesis of glaucoma is not fully understood, however, the level of intraocular pressure is being related with the retinal ganglion cell death. The balance between the secretion of aqueous humor by the ciliary body and its drainage through 2 independent pathways: i. the trabecular meshwork; and ii. uveoscleral outflow pathway, determines the intraocular pressure. In patients with open angle glaucoma, there is increased resistance to aqueous outflow through the trabecular meshwork. In contrast, the access to the drainage pathways is obstructed typically by the iris in patients with angle closure
Depending on how bad the demyelinating disease progressed, some patients have to go through much more than just oral medications to help the symptoms of optic neuritis. Some patients have to have IVIG (Intravenous immunoglobulin), first introduced in 1952, it contains pooled immunoglobulin from the plasma of over one thousand donors. Other patients get Interferon Injections, which is an antiviral medication that has a protein found in our bodies to help aid the symptoms of optic neuritis. There is also Intravenous methyl prednisone a steroid to treat inflammation of the optic nerve. Whatever the treatment you receive, it is imperative to get to the eye Dr. as soon as possible, the sooner your seen and diagnosed, the sooner your optic nerve will
Elimination of the possibility of pupillary block glaucoma by verifying or creating a patent iridectomy is essential. Miotic medications should be avoided, and vigorous cycloplegia as well as the use of topical steroids should be started. Aqueous suppressants and hyperosmotics can be used to reduce the pressure. The effect of medical therapy is often not immediate, but approximately 50% of cases will be relieved within 5 days.
Usually a surgical procedure for cataracts, cornea transplant or a vision complaint is necessary and may